Can losartan be used with Confin (Keratolytic agent)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

I do not recommend using losartan with Confin (Keratolytic agent) as there is no information available on the safety and efficacy of this combination. Losartan is an angiotensin II receptor blocker (ARB) used to treat high blood pressure and protect kidney function in certain conditions 1. If you're asking about combining losartan with a specific medication, please clarify the exact name of the second drug, as "Confin" is not a recognized medication in the provided evidence. Losartan does have several known drug interactions with medications like lithium, NSAIDs (such as ibuprofen), potassium supplements, and other blood pressure medications 1. These interactions can lead to increased side effects or reduced effectiveness. Always consult with your healthcare provider before combining losartan with any other medication to ensure safety and appropriate treatment.

Key Considerations

  • Losartan is used to treat high blood pressure and protect kidney function in certain conditions 1.
  • There is no information available on the safety and efficacy of combining losartan with Confin (Keratolytic agent) 1.
  • Losartan has known drug interactions with medications like lithium, NSAIDs, potassium supplements, and other blood pressure medications 1.
  • Consult with your healthcare provider before combining losartan with any other medication to ensure safety and appropriate treatment.

Recommendations

  • Consult with your healthcare provider before combining losartan with any other medication.
  • Monitor blood pressure and kidney function regularly while taking losartan 1.
  • Be aware of potential drug interactions with losartan and take steps to minimize risks 1.

From the Research

Losartan and Confin (Keratolytic agent) Interaction

There is no direct evidence in the provided studies to suggest an interaction between losartan and Confin (Keratolytic agent).

Renal Function and Losartan

  • Losartan may cause renal dysfunction in certain patients, particularly those with bilateral renal artery stenosis, severe congestive heart failure, and severe sodium and volume depletion 2.
  • The ELITE trial showed a 10.5% incidence of losartan-induced renal dysfunction in elderly patients with congestive heart failure with no known underlying renal dysfunction 2.
  • Losartan has been shown to reduce the incidence of doubling of serum creatinine, end-stage renal disease, or death in patients with type 2 diabetes mellitus and proteinuria 3, 4.

Losartan and Other Medications

  • Losartan has been compared to ACE inhibitors in several studies, with some suggesting that losartan may have similar effects on kidney function 5, 3.
  • Losartan has been used in combination with other antihypertensive medications, such as calcium-channel antagonists, diuretics, alpha-blockers, beta-blockers, and centrally acting agents 4.

Monitoring and Precautions

  • Renal function should be monitored in patients taking losartan, particularly in those with underlying renal dysfunction 2, 6.
  • Losartan should be used with caution in patients with risk factors for renal dysfunction, such as old age, preexisting chronic renal failure, stenosis of renal arteries, solitary kidney, and diuretic therapy 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Losartan in patients with renal insufficiency.

The Canadian journal of cardiology, 1995

Research

[Acute kidney failure and losartan: a recently observed event of antagonists of angiotensin II AT1 receptors].

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.